RecruitingPhase 3NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
Jackson, MS · +51 more sites
4 recruiting breast cancer studies with a site in Jackson, MS.
Sponsor: Relay Therapeutics, Inc.
Jackson, MS · +51 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Columbus, MS · Grenada, MS · Jackson, MS · +825 more sites
Sponsor: NRG Oncology
Columbus, MS · Grenada, MS · Jackson, MS · +378 more sites
Sponsor: SWOG Cancer Research Network
Columbus, MS · Grenada, MS · Jackson, MS · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.